comparemela.com

Latest Breaking News On - Dan ahrens - Page 13 : comparemela.com

Nextleaf Solutions Onboards New Partner and Delivers Initial Bulk CBD Order

Nextleaf Solutions Onboards New Partner and Delivers Initial Bulk CBD Order April 21 | 2021 Nextleaf Solutions Ltd. (CSE: OILS) (OTCQB: OILFF) (FSE: L0MA) (“Nextleaf”, “OILS”, or the “Company”) , the world’s most innovative cannabis processor, is pleased to announce that its wholly-owned subsidiary Nextleaf Labs Ltd. (“Nextleaf Labs” or “Labs”) has completed an inaugural bulk CBD distillate delivery to a U.S.-listed, Canadian-based global cannabis company. The Company anticipates similar orders on an ongoing basis. Cannot view this video? Visit: While the Canadian cannabis sector continues to mature as the world’s largest federally legal cannabis jurisdiction, the global demand and acceptance of CBD-based products continues to increase. In December 2020, Israel signed a regulatory amendment permitting the use of CBD in cosmetics and food products, and in February 2021 plant-derived CBD was added as a l

Robinhooders: Don t Blow Your Stimulus Check on Sundial Growers, Buy This Red-Hot Cannabis ETF Instead

Author Bio I love looking at the story behind investments from an interdisciplinary point of view, with an equal appetite for high-growth disruptors and beaten-down value names. There are a lot of interesting investment opportunities today, but perhaps none more exciting than cannabis specifically, U.S-based cannabis companies. Though marijuana is still federally illegal, many U.S. companies operating in states where marijuana use is legal are seeing booming financial results. Furthermore, the prospect of potential regulatory rollbacks means U.S. pot companies could also see improvements in their cost structures as well sometime during this administration.  Yet unfortunately, many U.S. investors are shut out from this promising opportunity. 

Marijuana ETFs Continue to Fly High as March Begins

March 1, 2021 Cannabis related ETFs have been on fire recently, and their outperformance has continued to start the month of March. Last week the AdvisorShares Pure US Cannabis ETF (MSOS) announced it had gathered over $1 billion in assets. The fund was up 2.2% Monday morning amid the news. The AdvisorShares ETF is the first of its kind to focus on U.S. cannabis equities. That’s beneficial seeing that the U.S. is the fastest-growing marijuana market in the world. “When it launched on September 2, 2020, the actively managed MSOS became the first U.S.-listed ETF focused solely on American cannabis companies, including multi-state operators (MSOs),” according to AdvisorShares. “MSOs are U.S. companies directly involved in the legal production and distribution of cannabis in states where approved. This ETF with its apt ticker seeks long-term capital appreciation by investing entirely in legal, domestic cannabis equity securities. Its domestic equity strategy allows MSOS

CURALEAF HLDGS INC by Curaleaf Hldgs Inc (CURLF), GW Pharma (GWPH) - Investors Have Been Flocking To This US Cannabis ETF

On Tuesday, AdvisorShares announced its AdvisorShares Pure US Cannabis ETF (NYSE:MSOS) crossed the threshold, making it just the second cannabis ETF to reach the mark. ETFMG Alternative Harvest ETF (NYSE:MJ) is the other.  MSOS made its debut on Sept. 2 with $2.5 million assets under management. It has since risen 93%. Speaking at the Benzinga Cannabis Conference Thursday, AdvisorShares Managing Director and Chief Operating Officer Dan Ahrens said the fund’s strong performance and growing popularity have been a direct result of its unique exposure to cannabis. “The difference was active management, active stock selection, and U.S. exposure,” he said. “All cannabis investing is not the same. In an actively managed fund, we can make choices any time we want or need. We want to have our hands on the steering wheel of these funds.”

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.